These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8193836

  • 1. Recent advances in the development and use of plasma concentrates.
    Soutar RL.
    Br J Hosp Med; ; 51(3):119-22. PubMed ID: 8193836
    [Abstract] [Full Text] [Related]

  • 2. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 2000 Sep 29; 10(39):357-8. PubMed ID: 11048427
    [No Abstract] [Full Text] [Related]

  • 3. HIV infection transmitted through blood product treatment, blood transfusion, and tissue transplantation.
    Mortimer JY, Spooner RJ.
    Commun Dis Rep CDR Rev; 1997 Aug 22; 7(9):R130-2. PubMed ID: 9293138
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Threatened future of plasma products. Who is responsible?].
    Berntorp E, Nilsson IM, Wollheim FA.
    Lakartidningen; 1996 Oct 02; 93(40):3443-4. PubMed ID: 8926816
    [No Abstract] [Full Text] [Related]

  • 7. [Substitution therapy of hemorrhagic diseases].
    Haupt H.
    Anasthesiol Intensivmed Prax; 1975 Oct 02; 11(1):137-44. PubMed ID: 1225069
    [No Abstract] [Full Text] [Related]

  • 8. [Blood derivatives in the treatment of hemophilia in Spain. Present and future needs].
    Medarde A, Ayesa C, Alfonso L, Muñóz A.
    Sangre (Barc); 1979 Oct 02; 24(5-C):942-6. PubMed ID: 121170
    [No Abstract] [Full Text] [Related]

  • 9. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ, Mathews RW, Fulton AJ.
    Clin Haematol; 1984 Feb 02; 13(1):3-15. PubMed ID: 6426834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transfusion and coagulation factor-acquired human immunodeficiency virus infection.
    Eyster ME.
    Pediatr Infect Dis J; 1991 Jan 02; 10(1):50-6. PubMed ID: 2003056
    [No Abstract] [Full Text] [Related]

  • 12. Blood products for hemophilia: past, present and future.
    Giangrande PL.
    BioDrugs; 2004 Jan 02; 18(4):225-34. PubMed ID: 15244500
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical perspectives of emerging pathogens in bleeding disorders.
    Ludlam CA, Powderly WG, Bozzette S, Diamond M, Koerper MA, Kulkarni R, Ritchie B, Siegel J, Simmonds P, Stanley S, Tapper ML, von Depka M.
    Lancet; 2006 Jan 21; 367(9506):252-61. PubMed ID: 16427495
    [Abstract] [Full Text] [Related]

  • 20. [News in the treatment of patients with hemophilia. Virus-inactivated coagulation factor concentrates, artificial joints and prenatal diagnosis].
    Stavem P, Evensen SA, Solheim B, Teigland JC.
    Tidsskr Nor Laegeforen; 1989 May 20; 109(14):1539-42. PubMed ID: 2749644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.